Accuracy of CardioWatch 287-2 During Profound Hypoxia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Pulse Oximetry
研究概览
简要总结
In an individual's SpO2 range from 100 to 73 %, this study calibrates and evaluates the accuracy of SpO2 measurement by CW2 in comparison to reference pulse oximeter (Nellcor PM10) or CO-oximetry, Pulse rate (PR) and respiratory rate (RR) were calibrated based on the same Nellcor equipment and the frequency of end-tidal CO2 respectively.
详细描述
The study is designed in accordance with Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment ISO 80601-2-61:2017, Corrected version 2018-02 and ISO 80601-2-55.
SpO2: Testing to confirm the accuracy of the SpO2 monitoring according to ISO 80601-2-61 Clause 201.12.1.101 201.12.1.101
RR Testing: Testing to confirm the accuracy of the respiration rate monitoring according to ISO 80601-2-55. Volunteers respirated spontaneously, no efforts were made to include all ranges of respiration during the study.
PR Testing: Testing to confirm the accuracy of the PR monitoring according to ISO 80601-2-61 Clause 201.12.1.104. No efforts were made to influence PRs of volunteers.
An accelerometer and PPG filters are built in CW2 in order to form the basis to exclude non-eligible test results.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy non-disabled subjects with American Society of Anesthesiologists health score (ASA) of 1 or
- •The subject is aged ≥18 and ≤ 65 years.
- •The subject is not intellectual disabled, and has provided informed consent and is willing to comply with the study procedures.
排除标准
- •Heavy smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhemoglobin levels.
- •Individuals subject to conditions that result in elevated levels of methemoglobin
- •Individuals with hypoxia (SpO2 < 95 % at 21 % of oxygen)
- •Severe claustrophobia
- •Subject is known with altitude disease
- •The subject is obese (BMI ≥ 31 kg/m2).
- •The subject has a known history of moderate to severe heart disease, lung disease, kidney or liver disease.
- •The subject is diagnosed with moderate to severe asthma.
- •The subject is known with a hemoglobinopathy or history of anemia, e.g. sickle cell anemia, thalassemia, ... who, in the opinion of the investigator, would make them unsuitable for study participation.
- •The subject has any other serious systemic illness.
- •Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly.
- •The subject has a history of fainting or vasovagal response.
- •The subject has a history of sensitivity or allergy to local anesthetics or disinfectants.
- •The subject has a diagnosis of Raynaud's disease.
- •The subject has unacceptable collateral circulation based on exam by the investigator.
- •The subject is pregnant, lactating or trying to get pregnant.
- •The subject is unable or unwilling to provide informed consent or is unable or unwilling to comply with study procedures.
- •The subject has any other condition, which in the opinion of the investigators would make the subject unsuitable for the study.
- •The subject refuses to remove nail-vanish.
研究组 & 干预措施
Single group
Each participant wore one CW2 sensor attached to the back of the wrist with a wrist band. Additionally, each participant wore a reference pulse oximeter (Nellcor PM10) attached to the middle finger of the ipsilateral hand. This enabled the comparison of the paired results of the CW2 sensor and reference pulse oximeter equipment for SpO2 measurements at different oxygen saturation levels. Twelve subjects of the 24 participants received an arterial catheter in the contralateral radial artery for exvivo SaO2 determination by CO-oximetry and in order to define the final accuracy of CW2 for SpO2 measurement.
干预措施: CardioWatch 287-2 (Device)
结局指标
主要结局
Pulse Oximetry
时间窗: 1 hour
SpO2
Pulse rate
时间窗: 1 hour
Heart rate in beats per minutes
Respiratory rate
时间窗: 1 hour
In breaths per minutes
次要结局
未报告次要终点